January 17, 2023
Life Sciences
  • Pfizer Inc. said it will sell its drugs to 45 low-income countries at a not-for-profit price, including off-patent medicines like chemotherapies and oral cancer treatments. The pharmaceutical manufacturer will now offer 500 products as part of a program to increase treatment access in poorer countries after only offering its patented medicines at a not-for-profit price when the initiative began last May. (Articles here and here)